Chelatotherapy in multiple sclerosis. Open preliminary study of a new therapeutical principle applied in multiple sclerosis--public health topic.
D000328:Adult; D000818:Animals; D002125:Calcium Gluconate / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003545:Cysteine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004492:Edetic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects; D013997:Time Factors
D002614:Chelating Agents; D004338:Drug Combinations; C044148:rodilemid; D004492:Edetic Acid; D003545:Cysteine; D002125:Calcium Gluconate